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Clinimetric Properties of the Motor Activity Log for the
Assessment of Arm Use in Hemiparetic Patients
J.H. van der Lee, MD, PhD; H. Beckerman, PT, PhD; D.L. Knol, PhD;
H.C.W. de Vet, PhD; L.M. Bouter, PhD
Background and Purpose—The Motor Activity Log (MAL) is a semistructured interview for hemiparetic stroke patients
to assess the use of their paretic arm and hand (amount of use [AOU]) and quality of movement [QOM]) during activities
of daily living. Scores range from 0 to 5. The following clinimetric properties of the MAL were quantified: internal
consistency (Cronbach ), test–retest agreement (Bland and Altman method), cross-sectional construct validity
(correlation between AOU and QOM and with the Action Research Arm [ARA] test), longitudinal construct validity
(correlation of change on the MAL during the intervention with a global change rating [GCR] and with change on the
ARA), and responsiveness (effect size).
Methods—Two baseline measurements 2 weeks apart and 1 follow-up measurement immediately after 2 weeks of intensive
exercise therapy either with or without immobilization of the unimpaired arm (forced use) were performed in 56 chronic
stroke patients.
Results—Internal consistency was high (AOU: 0.88; QOM: 0.91). The limits of agreement were 0.70 to 0.85 and
0.61 to 0.71 for AOU and QOM, respectively. The correlation with the ARA score (Spearman ) was 0.63 (AOU and
QOM). However, the improvement on the MAL during the intervention was only weakly related to the GCR and to the
improvement on the ARA, Spearman was between 0.16 and 0.22. The responsiveness ratio was 1.9 (AOU) and 2.0 (QOM).
Conclusion—The MAL is internally consistent and relatively stable in chronic stroke patients not undergoing an
intervention. The cross-sectional construct validity of the MAL is reasonable, but the results raise doubt about its
longitudinal construct validity. (Stroke. 2004;35:1410-1414.)
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Constraint-induced movement therapy (CIMT) is a type oftreatment for hemiparetic stroke patients, in which pa-
tients are strongly encouraged to use the affected arm.1 The
purpose of this treatment is to overcome the “learned nonuse”
of the affected arm. Learned nonuse is hypothesized to result
from a psychological process in which attempts to use the
affected arm during the acute and subacute stages after stroke
are “punished” by failure.2 Overcoming learned nonuse is
meant to result in enhanced quantity and quality of the
partaking of the affected arm in activities of daily living. The
Motor Activity Log (MAL) was developed to measure this
improvement.3 Most researchers investigating the effect of
CIMT use additional outcome measures other than the MAL,
such as the Wolf Motor Function Test,4 the Arm Motor
Activity Test,5 the Fugl-Meyer Assessment scale,6 or the
Action Research Arm test,7 which are all performance mea-
sures. The MAL consists of a semi-structured interview for
the patient to assess the use of the paretic arm and hand
during activities of daily living. Two scores are given for each
activity, 1 for the amount of use (AOU) and 1 for the quality
of movement (QOM) of the paretic arm. The questions
concern activities performed during the past week or, occa-
sionally, the past year.3 After an initial screening question to
verify that the activity at issue has been performed during the
time-frame at issue, the patient is asked how much the
affected arm participated in this activity. Possible scores
range from 0 (never use the affected arm for this activity) to
5 (always use the affected arm for this activity). To measure
QOM, the patient is asked how well the affected arm helped
during this activity. Possible scores range from 0 (inability to
use the affected arm for this activity) to 5 (ability to use the
affected arm for this activity just as well as before the stroke).
Since the MAL was first mentioned in a publication,3 it has
been used in a number of studies investigating the effect of
CIMT.8–14 However, no study in which the clinimetric
properties of the MAL were investigated has yet been
published. Moreover, the number of activities measured and
the way the instrument is applied varies between studies.
Different publications report on 14,3 20,8 26,10 or 30 activi-
ties.11 In some studies, all the questions on the MAL were
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addressed during 1 interview;10 but in other studies, the MAL
was divided into 2 parts, and each part was filled in every
other day on alternating days during the treatment.9 In most
studies, all the questions concerned the affected arm and
hand, but in 1 study 5 of the 20 items concerned the
unaffected arm, which served as a type of control or index for
comparison.14 Apart from the variation in the number of
activities and the way in which the interview is performed,
the sum score is also calculated differently by various
authors. Several authors present the number of activities in
which the affected hand participated, either in addition to or
instead of the overall sum score of the AOU on all activities
that have been performed.3,11,13 Claims of good internal
consistency,15 test–retest reliability,11 and inter-rater reliabil-
ity16 are not supported by published data, which might enable
other researchers to estimate their value.
If a measuring instrument is to be used as a primary
outcome measure in clinical studies, its internal consistency,
reproducibility, and validity must be satisfactory, and its
responsiveness must be sufficient to detect changes that are
considered to be clinically relevant. From the literature
reviewed, there seems to be no consensus about the content of
the MAL, how to apply it, or how to calculate a sum score.
In a randomized controlled trial performed in the Nether-
lands to investigate the effect of forced use (one of the
possible approaches in CIMT) in chronic stroke patients,10 a
translated and adapted version of the MAL developed by
Taub et al3 was used as an outcome measure. The aim of the
present validation study is to determine the internal consis-
tency, test–retest agreement, cross-sectional and longitudinal
construct validity, and responsiveness of this instrument.
Patients and Methods
In the randomized controlled trial reported in detail elsewhere,10 66
patients participated. The most relevant inclusion criteria were: (1) a
history of a single stroke, at least 1 year previously, resulting in a
hemiparesis on the dominant side; (2) Action Research Arm (ARA)
test score at intake 51 (maximum score: 57); (3) no severe aphasia
(score P50 on the Stichting Afasie Nederland (SAN) test17); and
(4) Mini Mental State Examination score of 22.18 The protocol was
approved by the University Medical Center Ethics Committee, and
all patients gave written informed consent.
Design
Two baseline measurements were performed, with a 2-week interval
before the intervention. The study population was considered to be
stable during the period between these 2 measurements because the
patients were all in the chronic poststroke phase.19 The experimental
intervention, consisting of immobilization of the unaffected arm by
means of a splint and sling, combined with intensive training of the
affected arm (6 hours per day, 5 days per week, 2 weeks) was
compared with an equally intensive reference intervention of biman-
ual training.10 A follow-up measurement took place within 1 week
after the 2-week intervention period. Patients in both intervention
groups improved, although a differential treatment effect was
found.10 At all 3 measurements, the MAL was filled in and the ARA
test was performed. At the end of the intervention period, the patients
reported the change in arm and hand function on a global change
rating (GCR) scale.
Measurement Instruments
A translated and adapted version of the MAL was used,3 which
contains the 14 original activities, 11 additional activities, and 1
optional activity chosen by the patient. The list of activities and the
rating procedure are shown in the Appendix. The purpose of adding
activities to the original MAL was to try to make it more responsive.
The minimal clinically important difference (MCID) was arbitrarily
set at 10% of the range of the scale, ie, 0.5 points.10
The ARA test is a performance test in which the ability to perform
gross movements and the ability to grasp, move, and release objects
differing in size, weight, and shape is tested.7 The original test
consisted of 19 items, rated on a 4-point ordinal scale (0 to 3). By
removing 4 items, a hierarchical 1-dimensional scale was construct-
ed.20 Adding the 15 item scores together yields a sum score that
ranges from 0 (none of the movements can be performed) to 45 (all
movements are performed without difficulty). The ARA test has
been shown to be valid, reliable, and responsive.21–23
At the end of the treatment period, the patients filled in a short
questionnaire to evaluate their treatment and compliance. One of the
questions was a GCR and was phrased, “Compared with 2 weeks
ago, the functioning of my arm and hand is. . . ”. The response
categories were “much worse,” “worse,” “somewhat worse,” “not
better, not worse,” “somewhat better,” “better,” and “much better.”
Statistical Analysis
Although all analyses were performed for the original MAL (14
activities) and for the adapted MAL (26 activities), only the results
of the original version are presented here. The internal consistency of
the MAL during the first baseline measurement was assessed by
means of Cronbach ,24 at first based on the original data and then
also after substitution of missing values for the activities that had not
been performed by the patient during the past week with corrected
item means.25,26 For all other analyses, data were complete for 56
subjects. The Bland and Altman method was used to evaluate the
test–retest agreement during the baseline period.27 The upper and
lower limits of agreement represent the “error thresholds.” Assuming
a normal distribution of the differences, only slightly 95% of the
differences between the 2 measurements per individual in a stable
population will be between these limits.27 The cross-sectional con-
struct validity was assessed by correlation of the first baseline AOU
and QOM scores with each other and with the first baseline ARA
score. The longitudinal construct validity was assessed by correlation
of the change in score during the intervention (both intervention
groups) with the change measured by different instruments (ie,
change on the ARA and the GCR), and by comparing the change
during the intervention with the change in the stable baseline period
(responsiveness ratio). The responsiveness ratio was calculated as
the ratio of the mean change after the intervention and the standard
deviation of the mean change during the baseline period.28 It can be
interpreted as the ability of the instrument to detect a change
expressed as an effect size normalized for the variability in a stable
population. A greater responsiveness ratio in the 26-item version
compared with the 14-item version would justify the use of this
extended version.
Results
Of the 66 patients who entered the study, 62 completed the
treatment. One week follow-up measurements were obtained
from 61 patients.10 Data on the GCR were missing for 5
cases, because of organizational error. The results presented
here are based on the data from 56 patients. The baseline
characteristics of these patients are shown in Table 1.
Several patients reported that they had not performed a
number of activities on the MAL during the past week. The
internal consistency of the MAL, assessed by Cronbach  on
the data of the 29 patients who had performed all 14
activities, was 0.88 and 0.91 for the AOU and QOM scales,
respectively. After substitution of the missing values for the
activities that had not been performed with corrected item
means, Cronbach  was 0.87 and 0.90 for the AOU and QOM
scales, respectively (n56).
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The Bland and Altman plots illustrating the test–retest
agreement are shown in Figures 1 and 2.
The means and standard deviations of the MAL AOU and
QOM scores at the 3 measurement points are shown in Table
2. The mean differences between the 2 baseline measure-
ments did not differ significantly from 0, and the limits of
agreement were 12% to 15% of the range of the scale. Any
difference that is between these limits is likely to be caused
by “noise” or measurement error.
Spearman rank correlation coefficient between the AOU
and QOM scores at the first baseline measurement was 0.95
(P0.001); between the MAL and the ARA, the Spearman 
was 0.63 (P0.001) for the AOU and QOM scores. The
correlation between the change on the MAL and the change
on the ARA during the treatment period was weak and not
statistically significant (Spearman 0.16 and P0.23 for
the AOU scale; 0.16 and P0.25 for the QOM scale).
Irrespective of the type of treatment they received, virtually
all patients expressed a positive opinion about the effects of
their treatment, which is evident from their GCR answers.
None of the patients chose any of the “worse” categories.
Two patients reported that their arm and hand function had
not changed, 23 stated that it was “somewhat better,” 26 felt
that it was “better,” and 5 patients considered their arm and
hand function to be “much better” than before the interven-
tion. There was a weak and nonsignificant correlation be-
tween the change score on the MAL during treatment and the
GCR (Spearman 0.20 and P0.15 for the AOU scale;
Spearman 0.22 and P0.10 for the QOM scale). The
responsiveness ratio is also shown in Table 2.
The analyses of the adapted MAL containing 26 activities
(data not shown) showed remarkably similar results. Becaue
the aim of adding activities was to improve the responsive-
ness of the instrument, the responsiveness ratio was the most
interesting parameter. This was 1.7 and 2.0 for the AOU and
QOM, respectively.
TABLE 1. Baseline Characteristics of the 56 Chronic Stroke
Patients Included in the Study
Median age (interquartile range) 61 (5266)
Median years since stroke (interquartile range) 3.2 (2.15.1)
Females (%) 24 (43)
Diagnosis of hemorrhage (%) 13 (23)
Left-sided hemiparesis (%) 10 (18)
Sensory disorders present (%) 24 (43)
Hemineglect present (%) 5 (9)
Median baseline* ARA† score (interquartile range) 30.0 (18.632.9)
Median baseline* MAL AOU‡ score (interquartile range) 1.45 (0.822.33)
Median baseline* MAL QOM§ score (interquartile range) 1.21 (0.701.70)
*Mean of both baseline measurements per patient.
†ARA, Action Research Arm test, possible range 0–45.
‡MAL AOU, MAL amount of use scale, possible range 0–5.
§MAL QOM, MAL quality of movement scale, possible range 0–5.
Figure 1. Scatter-plot of the difference between the 2 baseline
MAL AOU scores and the mean baseline score per individual.
The horizontal lines indicate the mean difference (middle) and
the upper and lower limits of agreement.
Figure 2. Scatter-plot of the difference between the 2 baseline
MAL QOM scores and the mean baseline score per individual.
The horizontal lines indicate the mean difference (middle) and
the upper and lower limits of agreement.
TABLE 2. Means and Standard Deviations (SD) of MAL
Amount of Use (AOU) and Quality of Movement (QOM) Scores at
3 Subsequent Measurement Points and of Differences Between
these Measurements. Limits of Agreement, Responsiveness
Ratios (n56)
MAL AOU MAL QOM
Mean SD Mean SD
Baseline 1 1.66 1.12 1.37 1.00
Change during baseline 0.07 0.39 0.05 0.33
Baseline 2 1.73 1.07 1.42 0.96
Change during intervention 0.76 0.62 0.66 0.62
Follow-up 2.48 1.15 2.08 1.04
Limits of agreement* 0.70 to 0.85 0.61 to 0.71
Responsiveness ratio† 1.9 2.0
*Mean difference baseline 2 SD difference baseline.
†Responsiveness ratio  (mean change during intervention) divided by
(standard deviation of change baseline).
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Discussion
Contrary to what is suggested in the literature, the standard
MAL does not exist. As described in the introduction,
different questions are posed to patients in different ways by
different authors who present their findings on the MAL.
However, considering the good internal consistency, the
choice of activities included in the interview may not be of
crucial importance. This is supported by the similarity of the
results presented here for the original version containing 14
activities and the adapted version containing 26 activities.
The test–retest agreement shows that the MAL was rela-
tively stable in this population of chronic stroke patients, but
it also shows that changes must be12% to 15% of the range
of the scale to exceed the measurement error. This means that
the reproducibility of this instrument is insufficient to detect
a change of 10% of the range of the scale, which was
proposed as the MCID. This renders the MAL less suitable
for use in clinical practice but poses no large problem for use
in clinical research.
A more serious problem is to decide what a change on the
MAL implies, even if it exceeds the limits of agreement. One
would expect a positive correlation between improvement on
the MAL and improvement on the ARA test, indicating that
patients whose dexterity improves make more use of the
affected arm and hand. Although there is a reasonable
cross-sectional correlation, indicating more hand-use in pa-
tients with better dexterity at baseline, the changes on both
measures are virtually unrelated. How can this lack of
correlation be explained? Obviously, the ARA and the MAL
measure different constructs, with the ARA being a perfor-
mance test and the MAL providing a subjective rating of the
use of the affected arm and hand in daily life. Nevertheless,
considering the correlation between the baseline scores on
both measures, the lack of correlation in the change scores is
surprising. A similar problem is posed by the lack of
correlation between the change on the MAL and the GCR.
Apparently, patients who consider their arm function to be
improved (as reflected by their GCR) do not notice that they
use their arm and hand more in daily life, and vice versa. Both
the GCR and the MAL are concerned with the patient’s
opinion of “how well the affected arm works.” However, a
certain amount of social desirability may be reflected in the
GCR, because virtually all patients stated that their arm
function was at least somewhat better. Contrary to the MAL
interview, which was performed by an investigator who was
blinded to the allocation of the intervention, the GCR ques-
tions were answered in the presence of the physiotherapist
who supervised the treatment. This may have enhanced the
risk of socially desirable answers. Apart from that, it is not
surprising that patients in this study, who have invested so
much time and effort in trying to improve, estimate their
improvement very positively immediately after this period of
intensive training. The general positive attitude of patients at
the end of the treatment may have led to unduly optimistic
ratings at this time. Although the validity of a retrospective
assessment such as the GCR can be questioned,29 the virtually
absent longitudinal correlations with the ARA and the GCR
leave us with considerable doubt about the longitudinal
construct validity of the MAL. The best way to obtain valid
information about the use of the affected arm and hand in
daily life would obviously be to observe the patient in the
home environment or by using activity-monitoring devic-
es.30,31 The responsiveness ratios of 1.9 and 2.0, which can be
interpreted as an effect size, indicate a considerable change
during the treatment period, compared with the baseline
period. However, as stated before, it is not clear what this
change actually implies, because it is not related to the change
in comparable outcome measures.
In conclusion, the MAL is internally consistent, relatively
stable in a population of chronic stroke patients, and its
reproducibility is sufficient to detect an individual change of
at least 12% to 15% of the range of the scale. Although the
cross-sectional correlation with the ARA is reasonably good
and the responsiveness ratio shows a considerable effect size
in chronic patients undergoing intensive training of the
affected arm and hand, there are reasons to doubt the
longitudinal construct validity of the instrument. Therefore,
use of the MAL as a primary outcome measure in clinical
trials is not recommended.
Appendix
Activities in the Dutch 26-Item Motor Activity Log
For each activity the first question is:
Did you perform this activity during the past week? If the answer
is “No,” the score is “Not applicable.” If the answer is “Yes,” the
next questions are:
How much did your affected arm participate in this activity?
(AOU scale) Possible scores range from 0 (never/not at all) to 5
(always/during all the time); and
How well did your affected arm help during this activity?
(QOM scale) Possible scores range from 0 (inability to use the
Activities in Original Version
(Taub 1993)
Additional Activities in Dutch Version
(Van der Lee 1999)
Steady oneself while standing* Pour coffee/tea
Put arm through sleeve of clothing Peel fruit or potatoes
Carry an object in hand from place
to place
Dial a number on the phone
Eat with knife and fork† Open/close a window
Comb hair Open an envelope
Pick up cup by handle Take money out of a wallet/purse
Handcraft/card playing/hobbies‡ Undo buttons on clothing
Hold a book, journal or
magazine/turn pages for reading§
Do up buttons on clothing
Use towel to dry face or other part
of the body
Undo a zip
Pick up glass Do up a zip
Pick up tooth-brush and brush
teeth
Cut nails
Shaving/make-up Other optional activity
Use key to open door
Letter writing/typing
*Original version: steady myself while standing.
†Original version: Pick up fork or spoon and use for eating.
‡Original version: Handcraft/card playing.
§Original version: Hold a book for reading.
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affected arm for this activity) to 5 (ability to use the affected arm
just as well as before the stroke).
Sum scores are calculated for the amount of use and quality of
movement scales separately. To calculate the sum score, the sum of
the activity scores is divided by the number of activities performed.
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